177 papers found
Refreshing results…
Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort study
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV co-infected patients from Côte d’Ivoire
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma
Significant Reduction in HIV Virologic Failure During a 15-Year Period in a Setting With Free Healthcare Access
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length gag–protease genes
Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1: Atripla® in Naıve Patients Infected With HIV
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications
French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): A multicentre, phase 2, non-comparative, open-label, randomised trial
Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV
Failure of Fourth-Generation Enzyme Immunoassay in HIV Screening and Plasma HIV-1 RNA Detection in Recent High-Risk Behavior
Effect of Tenofovir With and Without Interferon on Hepatitis D Virus Replication in HIV–Hepatitis B Virus–Hepatitis D Virus-Infected Patients
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
Clinical Evaluation of BioPlex 2200 HIV Ag-Ab, an Automated Screening Method Providing Discrete Detection of HIV-1 p24 Antigen, HIV-1 Antibody, and HIV-2 Antibody
Higher Specificity of Nucleic Acid Sequence-Based Amplification Isothermal Technology than of Real-Time PCR for Quantification of HIV-1 RNA on Dried Blood Spots
Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations
Pressure from TRIM5 Contributes to Control of HIV-1 Replication by Individuals Expressing Protective HLA-B Alleles
Missing publications? Read more about our data sources.